|
Balt usa reference complaint #(b)(4).The unit with the label discrepancy has been returned to balt usa under rga (b)(4).This complaint has triggered the opening of hhe-(b)(4) (balt usa co#(b)(4)) and ncmr (b)(4) to drive completion of the hhe.Any further corrective action and investigation will be documented under the hhe and ncmr.(b)(6) 2021: while preparing hhe-(b)(4), the initial assessment of this complaint file was re-evaluated due to feedback received from the regulatory department regarding the hhe.Upon initial assessment, the assumption of the label discrepancy was made that the shelf carton label was incorrect, and the pouch label was correct according to the lhr.As recorded in balt usa ncmr (b)(4), one additional unit was returned from balt extrusion under rga (b)(4) ((b)(6) 2021) after this complaint had already been closed.At the time of the initial assessment, the device pouch was not opened knowing that the unit had potential to be reworked.During the re-evaluation of this complaint, the pouch of both units were opened and the length of the implant was found to be 7cm, therefore the shelf carton label is correct and the pouch label is incorrect.This additional evaluation has been documented in balt usa ncmr (b)(4) and hhe-(b)(4).(b)(6) 2022: initial reportability decision tree deemed this event as not reportable.Reportability decision tree was not updated after the additional information was received regarding this incident.Reportability decision tree has been updated and has been deemed reportable.Notification of urgent field safety notice (fsn) / product recall was issued 04jan2022 with the reference "fsn #: 3014162263-01/04/22-001-r" for inside the united states.Additional reference "(b)(4)_optima labeling mix-up" used for outside the united states.Fda acknowledgement letter reference res# (b)(4).
|